Impact of Chronic Kidney Disease on In-Hospital Outcomes of Hospitalizations With Acute Limb Ischemia Undergoing Endovascular Therapy

Abstract

Purpose:

Studies on outcomes related to endovascular treatment (EVT) in advanced stages of chronic kidney disease (CKD) and end-stage renal disease (ESRD) among hospitalizations with acute limb ischemia (ALI) are limited.

Methods:

The Nationwide Inpatient Sample was quarried from October 2015 to December 2017 to identify the hospitalizations with ALI and undergoing EVT. The study population was subdivided into 3 groups based on their CKD stages: group 1 (No CKD, stage I, stage II), group 2 (CKD stage III, stage IV), and group 3 (CKD stage V and ESRD). The primary outcome was all-cause in-hospital mortality.

Results:

A total of 51 995 hospitalizations with ALI undergoing EVT were identified. The in-hospital mortality was significantly higher in group 2 (OR = 1.17; 95% CI 1.04 – 1.32, p=0.009) and group 3 (OR = 3.18; 95% CI 2.74–3.69, p<0.0001) compared with group 1. Odds of minor amputation, vascular complication, atherectomy, and blood transfusion were higher among groups 2 and 3 compared with group 1. Group 2 had higher odds of access site hemorrhage compared with groups 1 and 3, whereas group 3 had higher odds of major amputation, postprocedural infection, and postoperative hemorrhage compared with groups 1 and 2. Besides, groups 2 and 3 had lower odds of discharge to home compared with group 1. Finally, the length of hospital stay and cost of care was significantly higher with the advancing CKD stages.

Conclusion:

Advanced CKD stages and ESRD are associated with higher mortality, worse in-hospital outcomes and higher resource utilization among ALI hospitalizations undergoing EVT.

Clinical Impact

Current guidelines are not clear for the optimum first line treatment of acute limb ischemia, especially in patients with advanced kidney disease as compared to normal/mild kidney disease patients. We found that advanced kidney disease is a significant risk factor for worse in-hospital morbidity and mortality. Furthermore, patients with acute limb ischemia and advanced kidney disease is associated with significantly higher resource utilization as compared to patients with normal/mild kidney disease. This study suggests shared decision making between treating physician and patients when considering endovascular therapy for the treatment of acute limb ischemia in patients with advanced kidney disease.

Keywords

peripheral arterial disease acute limb ischemia endovascular treatment chronic kidney disease end-stage renal disease

Get full access to this article

View all access options for this article.

References

Creager

Kaufman

Conte

MS.

Clinical practice. Acute limb ischemia. N Engl J Med. 2012;366(23):2198–2206. doi:10.1056/NEJMcp1006054.

Hamady

Müller-Hülsbeck

European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia; a word of caution!

CVIR Endovasc. 2020;3(1):31. doi:10.1186/s42155-020-00122-5.

de Athayde Soares

Matielo

Brochado Neto

, et al Analysis of the safety and efficacy of the endovascular treatment for acute limb ischemia with percutaneous pharmacomechanical thrombectomy compared with catheter-directed thrombolysis. Ann Vasc Surg. 2020;66:470–478. doi:10.1016/j.avsg.2019.11.038.

Baril

Ghosh

Rosen

AB.

Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population. J Vasc Surg. 2014;60(3):669–677. doi:10.1016/j.jvs.2014.03.244.

Kolte

Kennedy

Shishehbor

, et al Endovascular versus surgical revascularization for acute limb ischemia: a propensity-score matched analysis. Circ Cardiovasc Interv. 2020;13(1):e008150. doi:10.1161/CIRCINTERVENTIONS.119.008150.

Anantha-Narayanan

Doshi

Patel

, et al Contemporary trends in hospital admissions and outcomes in patients with critical limb ischemia: an analysis from the national inpatient sample database. Circ Cardiovasc Qual Outcomes. 2021;14(2):e007539. doi:10.1161/CIRCOUTCOMES.120.007539.

Shishehbor

Jaff

MR.

Percutaneous therapies for peripheral artery disease. Circulation. 2016;134(24):2008–2027. doi:10.1161/CIRCULATIONAHA.116.022546.

Garimella

Hart

O’Hare

, et al Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis. 2012;60(4):641–654. doi:10.1053/j.ajkd.2012.02.340.

Zlatanovic

Koncar

Dragas

, et al Combined impact of chronic kidney disease and contrast induced acute kidney injury on long-term outcomes in patients with acute lower limb ischaemia. Eur J Vasc Endovasc Surg. 2018;56(1):78–86. doi:10.1016/j.ejvs.2018.03.008.

10.

Lüders

Bunzemeier

Engelbertz

, et al CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol. 2016;11(2):216–222. doi:10.2215/CJN.05600515.

11.

Health Cost and Utilization Project-User Support. NIS overview. Date unknown. https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed March 19, 2021.

12.

Hauguel

Maurel

Bague

, et al Management of ambulatory (day case) endovascular procedures for peripheral arterial disease. J Cardiovasc Surg (Torino). 2017;58(2):293–304. doi:10.23736/S0021-9509.17.09879-2.

13.

Thakkar

Patel

Chowdhury

, et al Impact of arrhythmias on hospitalizations in patients with cardiac amyloidosis. Am J Cardiol. 2021;143:125-130. doi:10.1016/j.amjcard.2020.12.024.

14.

Thakkar

Majmundar

Kumar

, et al Comparison of management and outcomes of acute heart failure hospitalization in Medicaid beneficiaries versus privately insured individuals. Am J Cardiol. 2020;125(7):1063–1068. doi:10.1016/j.amjcard.2019.12.047.

15.

O’Hare

Sidawy

Feinglass

, et al Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg. 2004;39(4):709–716. doi:10.1016/j.jvs.2003.11.038.

16.

Mak

Ikizler

Kovesdy

, et al Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011;2(1):9–25. doi:10.1007/s13539-011-0019-5.

17.

Kashyap

Gilani

Bena

, et al Endovascular therapy for acute limb ischemia. J Vasc Surg. 2011;53(2):340–346. doi:10.1016/j.jvs.2010.08.064.

18.

Pasqualini

Schillaci

Pirro

, et al. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. J Intern Med. 2007;262(6):668–677. doi: 10.1111/j.1365-2796.2007.01863.x.

19.

Lüders

Engelbertz

Meyborg

, et al Acute and chronic anemia and short- and long-term outcome of patients with peripheral arterial disease and critical limb ischemia. Eur J Intern Med. 2016;31:62–67. doi:10.1016/j.ejim.2016.03.002.

20.

Vega De Céniga

Bravo

Izagirre

, et al Anaemia, iron and vitamin deficits in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2011;41(6):828–830. doi:10.1016/j.ejvs.2011.01.017.

21.

Velescu

Clará

Cladellas

, et al Anemia increases mortality after open or endovascular treatment in patients with critical limb ischemia: a retrospective analysis. Eur J Vasc Endovasc Surg. 2016;51(4):543–549. doi:10.1016/j.ejvs.2015.12.006.

22.

McCoach

Armstrong

Singh

, et al Gender-related variation in the clinical presentation and outcomes of critical limb ischemia. Vasc Med. 2013;18(1):19–26. doi:10.1177/1358863X13475836.

23.

Traven

Synovec

Walton

, et al Notable racial and ethnic disparities persist in lower extremity amputations for critical limb ischemia and infection. J Am Acad Orthop Surg. 2020;28(21):885–892. doi:10.5435/JAAOS-D-19-00630.

24.

Fagundes

Fuchs

Fagundes

, et al Prognostic factors for amputation or death in patients submitted to vascular surgery for acute limb ischemia. Vasc Health Risk Manag. 2005;1(4):345–349. doi:10.2147/vhrm.2005.1.4.345.

25.

Yoshikawa

Kujime

Iwasaki

, et al Poor survival of dialysis patients with unhealed wounds because of critical limb ischemia: limb salvage and survival requires wound healing. Int Wound J. 2019;16(5):1112–1118. doi:10.1111/iwj.13162.

26.

Prasad

Ortiz-Lopez

Khan

, et al Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv. 2016;88(2):264–273. doi:10.1002/ccd.26466.

27.

Lüders

Bunzemeier

Engelbertz

, et al. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol. 2016;11(2):216–222. doi: 10.2215/CJN.05600515.

28.

Carl

Hoffman

Passmore

, et al Diabetic ketoacidosis promotes a prothrombotic state. Endocr Res. 2003;29(1):73–82. doi:10.1081/ERC-120018678.

29.

Heideman

Rajebi

McKusick

, et al Impact of chronic kidney disease on clinical outcomes of endovascular treatment for femoropopliteal arterial disease. J Vasc Interv Radiol. 2016;27(8):1204–1214. doi:10.1016/j.jvir.2016.04.036.

30.

Nativel

Schneider

Saulnier

, et al Prognostic values of inflammatory and redox status biomarkers on the risk of major lower-extremity artery disease in individuals with type 2 diabetes. Diabetes Care. 2018;41(10):2162–2169. doi:10.2337/dc18-0695.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB